NCT05373199 - A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 12, 2022

Primary Completion Date

October 28, 2022

Study Completion Date

October 28, 2022

Conditions

Type 1 Diabetes

Interventions

DRUG

Euglycemic clamp with BC Combo THDB0207

Administration of a single dose of BC Combo THDB0207 during an euglycemic clamp procedure.

DRUG

Euglycemic clamp with Lantus®

Administration of a single dose of Lantus® during an euglycemic clamp procedure.

DRUG

Euglycemic clamp with Humalog®

Administration of a single dose of Humalog® during an euglycemic clamp procedure.

Trial Locations (1)

Profil Institut für Stoffwechselforschung GmbH, Neuss